Search Results - "Kanter, Katie"

Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers by Parikh, Aparna R, Mojtahed, Amikasra, Schneider, Jaime L, Kanter, Katie, Van Seventer, Emily E, Fetter, Isobel J, Thabet, Ashraf, Fish, Madeleine G, Teshome, Bezaye, Fosbenner, Kathryn, Nadres, Brandon, Shahzade, Heather A, Allen, Jill N, Blaszkowsky, Lawrence S, Ryan, David P, Giantonio, Bruce, Goyal, Lipika, Nipp, Ryan D, Roeland, Eric, Weekes, Colin D, Wo, Jennifer Y, Zhu, Andrew X, Dias-Santagata, Dora, Iafrate, A John, Lennerz, Jochen K, Hong, Theodore S, Siravegna, Giulia, Horick, Nora, Clark, Jeffrey W, Corcoran, Ryan B

“…ctDNA offers a promising, noninvasive approach to monitor therapeutic efficacy in real-time. We explored whether the quantitative percent change in ctDNA early…”
Get full text

Muscle Loss Is Associated with Overall Survival in Patients with Metastatic Colorectal Cancer Independent of Tumor Mutational Status and Weight Loss by Best, Till Dominik, Roeland, Eric J., Horick, Nora K., Van Seventer, Emily E., El‐Jawahri, Areej, Troschel, Amelie S., Johnson, Patrick C., Kanter, Katie N., Fish, Madeleine G., Marquardt, J. Peter, Bridge, Christopher P., Temel, Jennifer S., Corcoran, Ryan B., Nipp, Ryan D., Fintelmann, Florian J.

“…Background Survival in patients with metastatic colorectal cancer (mCRC) has been associated with tumor mutational status, muscle loss, and weight loss. We…”
Get full text

Willingness to use a wearable device capable of detecting and reversing overdose among people who use opioids in Philadelphia by Kanter, Katie, Gallagher, Ryan, Eweje, Feyisope, Lee, Alexander, Gordon, David, Landy, Stephen, Gasior, Julia, Soto-Calderon, Haideliza, Cronholm, Peter F, Cocchiaro, Ben, Weimer, James, Roth, Alexis, Lankenau, Stephen, Brenner, Jacob

“…Abstract Background The incidence of opioid-related overdose deaths has been rising for 30 years and has been further exacerbated amidst the COVID-19 pandemic…”
Get full text

Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer by Parikh, Aparna R, Van Seventer, Emily E, Siravegna, Giulia, Hartwig, Anna V, Jaimovich, Ariel, He, Yupeng, Kanter, Katie, Fish, Madeleine G, Fosbenner, Kathryn D, Miao, Benchun, Phillips, Susannah, Carmichael, John H, Sharma, Nihaarika, Jarnagin, Joy, Baiev, Islam, Shah, Yojan S, Fetter, Isobel J, Shahzade, Heather A, Allen, Jill N, Blaszkowsky, Lawrence S, Clark, Jeffrey W, Dubois, Jon S, Franses, Joseph W, Giantonio, Bruce J, Goyal, Lipika, Klempner, Samuel J, Nipp, Ryan D, Roeland, Eric J, Ryan, David P, Weekes, Colin D, Wo, Jennifer Y, Hong, Theodore S, Bordeianou, Liliana, Ferrone, Cristina R, Qadan, Motaz, Kunitake, Hiroko, Berger, David, Ricciardi, Rocco, Cusack, James C, Raymond, Victoria M, Talasaz, AmirAli, Boland, Genevieve M, Corcoran, Ryan B

“…Detection of persistent circulating tumor DNA (ctDNA) after curative-intent surgery can identify patients with minimal residual disease (MRD) who will…”
Get full text

Low COMT and Stress Potentiate Functional Pain and Depressive Behavior, Especially in Female Mice by Zhang, Xin, Kanter, Katie, Chen, Jiegen, Kim, Seungtae, Wang, Yaomin, Adeyemi, Clementine, O’Buckley, Sandra C., Nackley, Andrea G.

Get full text

Low catechol-O-methyltransferase and stress potentiate functional pain and depressive behavior, especially in female mice by Zhang, Xin, Kanter, Katie, Chen, Jiegen, Kim, Seungtae, Wang, Yaomin, Adeyemi, Clementine, O'Buckley, Sandra C., Nackley, Andrea G.

“…Low levels of catechol-O-methyltransferase (COMT), an enzyme that metabolizes catecholamines, and stress, which potentiates catecholamine release from…”
Get full text

Measuring the Networked Nonprofit: Using Data to Change the World by Kanter, Beth, Paine, Katie Delahaye

“…The tools nonprofits need to measure the impact of their social mediaHaving a social media measurement plan and approach can no longer be an after-thought. It…”
Get full text

Associations of baseline patient‐reported outcomes with treatment outcomes in advanced gastrointestinal cancer by Seventer, Emily E., Fish, Madeleine G., Fosbenner, Kathryn, Kanter, Katie, Mojtahed, Amirkasra, Allen, Jill N., Blaszkowsky, Lawrence, Clark, Jeffrey W., Dubois, Jon, Franses, Joseph W., Giantonio, Bruce J., Goyal, Lipika, Klempner, Samuel J., Roeland, Eric J., Ryan, David P., Weekes, Colin D., Mulvey, Therese, El‐Jawahri, Areej, Horick, Nora, Corcoran, Ryan B., Parikh, Aparna R., Nipp, Ryan D.

“…Background Patient‐reported outcomes (PROs) assessing quality of life (QOL) and symptom burden correlate with clinical outcomes in patients with cancer…”
Get full text

Use of patient-reported outcomes (PROs) to predict treatment outcomes in patients with advanced cancer by Parikh, Aparna Raj, Van Seventer, Emily E., Fish, Madeleine, Fosbenner, Kathryn, Kanter, Katie, Mojtahed, Amirkasra, Allen, Jill N., Blaszkowsky, Lawrence Scott, Clark, Jeffrey William, Du Bois, Jon S., Franses, Joseph Wang, Giantonio, Bruce J., Goyal, Lipika, Klempner, Samuel J, Roeland, Eric, Ryan, David P., Weekes, Colin D., Horick, Nora K., Corcoran, Ryan Bruce, Nipp, Ryan David

“…Abstract only 186 Background: PROs assessing quality of life (QOL) and physical symptoms often correlate with clinical outcomes in patients (pts) with cancer…”
Get full text

Preliminary analysis of total neoadjuvant therapy for patients with locally advanced gastric (G) and gastroesophageal (GE) adenocarcinoma by Roeland, Eric, Kanter, Katie, Wo, Jennifer Yon-Li, Fish, Madeleine, Nipp, Ryan David, Van Seventer, Emily E., Parikh, Aparna Raj, Allen, Jill N., Giantonio, Bruce J., Blaszkowsky, Lawrence Scott, Keane, Florence, Klempner, Samuel J., Ryan, David P., Auchincloss, Hugh G., Ott, Harald, Lanuti, Michael, Morse, Christopher, Mullen, John Thomas, Hong, Theodore S.

“…Abstract only 393 Background: Nearly half of patients with G/GE cancer do not receive or complete post-operative chemotherapy and/or chemoradiation (CRT)…”
Get full text

The role of circulating tumor DNA (ctDNA), tumor markers (TMs), and patient-reported outcomes (PROs) in predicting treatment response in patients with metastatic gastrointestinal (GI) cancer by Parikh, Aparna Raj, Fish, Madeleine, Van Seventer, Emily E., Fosbenner, Kathryn, Kanter, Katie, Allen, Jill N., Clark, Jeffrey William, Giantonio, Bruce, Weekes, Colin D., Klempner, Samuel J., Franses, Joseph Wang, Roeland, Eric, Goyal, Lipika, Wo, Jennifer Yon-Li, Hong, Theodore S., Fetter, Isobel, Siravegna, Giulia, Horick, Nora K., Corcoran, Ryan Bruce, Nipp, Ryan David

“…Abstract only 833 Background: Changes in ctDNA and serum TMs (CEA and CA19-9) can serve as predictors of response to systemic therapy in GI cancer patients…”
Get full text

Minimal Residual Disease Detection using a Plasma-Only Circulating Tumor DNA Assay in Colorectal Cancer Patients by Parikh, Aparna R., van Seventer, Emily E., Siravegna, Giulia, Hartwig, Anna V., Jaimovich, Ariel, He, Yupeng, Kanter, Katie, Fish, Madeleine G., Fosbenner, Kathryn D., Miao, Benchun, Phillips, Susannah, Carmichael, John H., Sharma, Nihaarika, Jarnagin, Joy, Baiev, Islam, Shah, Yojan S., Fetter, Isobel J., Shahzade, Heather A., Allen, Jill N., Blaszkowsky, Lawrence S., Clark, Jeffrey W., Dubois, Jon S., Franses, Joseph W., Giantonio, Bruce J., Goyal, Lipika, Klempner, Samuel J., Nipp, Ryan D., Roeland, Eric J., Ryan, David P., Weekes, Colin D., Wo, Jennifer Y., Hong, Theodore S., Bordeianou, Liliana, Ferrone, Cristina R., Qadan, Motaz, Kunitake, Hiroko, Berger, David, Ricciardi, Rocco, Cusack, James C., Raymond, Victoria M., Talasaz, AmirAli, Boland, Genevieve M., Corcoran, Ryan B.

Get full text

Aggressiveness of care and overall survival in young metastatic colorectal cancer patients by Fish, Madeleine, Kanter, Katie, Mauri, Gianluca, Horick, Nora, Allen, Jill N, Blaszkowsky, Lawrence Scott, Clark, Jeffrey William, Ryan, David P., Nipp, Ryan David, Giantonio, Bruce J., Goyal, Lipika, Murphy, Janet E., Roeland, Eric, Weekes, Colin D., Wo, Jennifer Yon-Li, Hong, Theodore S., Zhu, Andrew X., Van Seventer, Emily E., Corcoran, Ryan Bruce, Parikh, Aparna Raj

“…Abstract only 3563 Background: Colorectal cancer (CRC) incidence in patients younger than 50 years of age is steadily rising by 2% annually. Early-onset CRC…”
Get full text

Low COMT and Stress Potentiate Functional Pain and Depressive Behavior, Especially in Female Mice by Zhang, Xin, Kanter, Katie, Chen, Jiegen, Kim, Seungtae, Wang, Yaomin, Adeyemi, Clementine, O'Buckley, Sandra C, Nackley, Andrea G

“…Low levels of catechol-O-methyltransferase (COMT), an enzyme that metabolizes catecholamines, and stress, which potentiates catecholamine release from…”
Get full text

Care Patterns and Overall Survival in Patients With Early-Onset Metastatic Colorectal Cancer by Kanter, Katie, Fish, Madeleine, Mauri, Gianluca, Horick, Nora K, Allen, Jill N, Blaszkowsky, Lawrence S, Clark, Jeffrey W, Ryan, David P, Nipp, Ryan D, Giantonio, Bruce J, Goyal, Lipika, Dubois, Jon, Murphy, Janet E, Franses, Joseph, Klempner, Samuel J, Roeland, Eric J, Weekes, Colin D, Wo, Jennifer Y, Hong, Theodore S, Van Seventer, Emily E, Corcoran, Ryan B, Parikh, Aparna R

“…Colorectal cancer (CRC) incidence in patients younger than 50 years of age, commonly defined as early-onset (EO-CRC), is rising. EO-CRC often presents with…”
Get more information

Running the Numbers: County Level Dynamics of Heroin Mortality in North Carolina by Gunn, Alexander H, Bartlett, Bryce, Feng, Grace, Gayed, Matthew, Kanter, Katie, Onuoha, Erica, Thornton, Madeline, Muzyk, Andrew, Schramm-Sapyta, Nicole

Get full text

Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial by Tian, Jun, Chen, Jonathan H, Chao, Sherry X, Pelka, Karin, Giannakis, Marios, Hess, Julian, Burke, Kelly, Jorgji, Vjola, Sindurakar, Princy, Braverman, Jonathan, Mehta, Arnav, Oka, Tomonori, Huang, Mei, Lieb, David, Spurrell, Maxwell, Allen, Jill N, Abrams, Thomas A, Clark, Jeffrey W, Enzinger, Andrea C, Enzinger, Peter C, Klempner, Samuel J, McCleary, Nadine J, Meyerhardt, Jeffrey A, Ryan, David P, Yurgelun, Matthew B, Kanter, Katie, Van Seventer, Emily E, Baiev, Islam, Chi, Gary, Jarnagin, Joy, Bradford, William B, Wong, Edmond, Michel, Alexa G, Fetter, Isobel J, Siravegna, Giulia, Gemma, Angelo J, Sharpe, Arlene, Demehri, Shadmehr, Leary, Rebecca, Campbell, Catarina D, Yilmaz, Omer, Getz, Gad A, Parikh, Aparna R, Hacohen, Nir, Corcoran, Ryan B

“…While BRAF inhibitor combinations with EGFR and/or MEK inhibitors have improved clinical efficacy in BRAF colorectal cancer (CRC), response rates remain low…”
Get full text